The Japanese pharmaceutical industry, a vital component of global innovation, faces a talent gap that resonates across multinational corporations. While Japan possesses a wealth of highly skilled professionals, a notable communication disparity impedes recruitment and career advancement, particularly in global…
HOME > BUSINESS
BUSINESS
- Mario Stein Named as New President of J&J Consumer Company
October 29, 2014
- Bristol’s Involvement in Sprycel Trial Could Contravene Ethics Code, but Not PAL: Probe
October 28, 2014
- US Judge Cuts Damages Takeda to Pay over Actos from US$6 Billion to US$27.65 Million
October 28, 2014
- GSK Files Lamictal Monotherapy for Typical Absence Seizures in Pediatric Patients
October 28, 2014
- NBI Files Spiriva-LABA Combination Drug for Approval
October 28, 2014
- 3 Major Wholesalers Acknowledge Illegal Diversion of Ethical Drugs to Wholesalers
October 28, 2014
- Xtandi Receives Positive CHMP Opinion for Treatment of Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer: Astellas
October 28, 2014
- Univ. of Tokyo, Pfizer Sign Strategic Partnership Deal for Drug Discovery Research
October 28, 2014
- Pfizer Japan Gearing Up for Reorganization in December, Pres. Umeda to Double as Head of New Unit
October 28, 2014
- PII Study Confirms Efficacy of Restless Legs Syndrome Treatment: Hisamitsu
October 28, 2014
- OTC Market Grew to 793 Billion Yen in 2013: Yano Research Institute
October 27, 2014
- Japan Arm of Hengrui Medicine Files Campto Generic for Approval
October 27, 2014
- Astellas Revises Package Insert for Xtandi Following Confirmation of Clinical Benefits in PIII Study
October 27, 2014
- Takeda Gains Worldwide Exclusive Rights for Amitiza Excluding Japan and China from Sucampo
October 24, 2014
- Toray Licenses Hemodialysis Pruritus Treatment to Orient EuroPharma in Taiwan
October 24, 2014
- Global Pharma Market to Reach US$1.3 Trillion by FY2018: IMS Official
October 23, 2014
- Taiho Receives Fast Track Designation from US FDA for Lonsurf
October 23, 2014
- US FDA Accepts sNDA for Fycompa: Eisai
October 23, 2014
- Taisho Files NDA for Anti-Inflammatory Analgesic Patch for Osteoarthritis
October 23, 2014
- Obesity Drug Contrave Hits US Pharmacy Shelves: Takeda
October 23, 2014
ページ
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…